Pliant Therapeutics, Inc. ( ($PLRX) ) has released its Q4 earnings. Here is a breakdown of the information Pliant Therapeutics, Inc. presented to ...

Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendationSOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE ...

Environmental activist Greta Thunberg spawned a new generation of youth eager to combat climate change. Foresight narratives ...

Pliant Therapeutics discontinued its BEACON-IPF trial for bexotegrast due to safety concerns but observed early efficacy. The ...

Pliant Therapeutics shares dropped 52% to $1.64, after the company said it was discontinuing a phase 2b trial for bexotegrast in patients with idiopathic pulmonary fibrosis. The stock hit its 52-week ...

Dr. Kelly is survived by his son, Ken, four adult grandchildren and 10 great grandchildren. In lieu of flowers, donations may ...

The trial, dubbed BEACON-IPF, was assessing the biotech’s lead candidate, an oral small molecule called bexotegrast. The ...

Getting rid of the military’s top lawyers is not exactly a sign that the Trump administration wants to follow the law.

National Cohesion and Integration Commission (NCIC) chairman Dr Samuel Kobia makes his remarks during the office of the ...

Immigrant rights groups say the move could impact how non-English speakers can become US citizens, vote, and access crucial ...

New York City deserves better than Andrew Cuomo. As frustrated as city residents rightfully are about the behavior of its ...